- Home
- HSII vs PAHC Comparison
HSII vs PAHC Comparison
Compare HSII & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSII
- PAHC
- Stock Information
- Founded
- HSII 1953
- PAHC 1946
- Country
- HSII United States
- PAHC United States
- Employees
- HSII N/A
- PAHC N/A
- Industry
- HSII Diversified Commercial Services
- PAHC Biotechnology: Pharmaceutical Preparations
- Sector
- HSII Consumer Discretionary
- PAHC Health Care
- Exchange
- HSII Nasdaq
- PAHC Nasdaq
- Market Cap
- HSII 904.3M
- PAHC 812.1M
- IPO Year
- HSII 1999
- PAHC 2014
- Fundamental
- Price
- HSII $46.09
- PAHC $20.82
- Analyst Decision
- HSII Buy
- PAHC Sell
- Analyst Count
- HSII 2
- PAHC 4
- Target Price
- HSII $46.00
- PAHC $20.50
- AVG Volume (30 Days)
- HSII 156.8K
- PAHC 183.3K
- Earning Date
- HSII 02-24-2025
- PAHC 02-05-2025
- Dividend Yield
- HSII 1.30%
- PAHC 2.88%
- EPS Growth
- HSII N/A
- PAHC N/A
- EPS
- HSII 1.83
- PAHC 0.43
- Revenue
- HSII $1,075,544,000.00
- PAHC $1,046,762,000.00
- Revenue This Year
- HSII $7.90
- PAHC $27.25
- Revenue Next Year
- HSII $3.07
- PAHC $14.13
- P/E Ratio
- HSII $25.23
- PAHC $48.45
- Revenue Growth
- HSII 6.55
- PAHC 7.17
- 52 Week Low
- HSII $27.07
- PAHC $10.04
- 52 Week High
- HSII $49.02
- PAHC $25.98
- Technical
- Relative Strength Index (RSI)
- HSII 62.14
- PAHC 42.91
- Support Level
- HSII $45.67
- PAHC $19.74
- Resistance Level
- HSII $46.48
- PAHC $21.82
- Average True Range (ATR)
- HSII 0.98
- PAHC 0.75
- MACD
- HSII 0.22
- PAHC 0.08
- Stochastic Oscillator
- HSII 89.20
- PAHC 51.43
About HSII Heidrick & Struggles International Inc.
Heidrick & Struggles International Inc is a leadership advisory firm providing executive search and consulting services to businesses and business leaders world wide. The company's operating segments includes the executive search business which operates in the Americas; Europe; Asia Pacific and On-Demand Talent and Heidrick Consulting. It generates maximum revenue from the Americas.
About PAHC Phibro Animal Health Corporation
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.